english
stringlengths 2
1.37k
|
---|
3.
|
pre-filled pen (glass) (OptiSet)
|
16.
|
Following subcutaneous injection, serum levels of epoetin alfa are much lower than the levels achieved following intravenous injection, the levels increase slowly and reach a peak between 12 and
|
Actraphane 40 Penfill
|
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION
|
You and your partner will need to engage in foreplay, just as you would if you were not taking a medicine for erectile dysfunction.
|
6.3 Shelf-life
|
8.
|
Preparation of the 70 mg/ m2 infusion for paediatric patients > 3 months of age (using a 70-mg vial) 1.
|
16.
|
No specific information is available on the treatment of overdose with Aprovel.
|
117 MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
|
6 ml
|
Excipients
|
If you have questions about how to inject, please ask your doctor, nurse or pharmacist for assistance.
|
480 soft capsules
|
BLISTER
|
The frequency of administration will depend on how well ADVATE is working for you.
|
Frequency of doses (hours)/duration of therapy (days)
|
CIALIS 10 mg film-coated tablets tadalafil
|
Therapy with AVAGLIM should not be initiated in patients with increased baseline liver enzyme levels (ALT > 2.5X upper limit of normal) or with any other evidence of liver disease.
|
Uncommon - Diabetic retinopathy Long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy.
|
SANOFI SYNTHELABO LIMITED Edgefield Avenue - Fawdon Newcastle Upon Tyne, Tyne & Wear NE3 3TT - United Kingdom
|
Water or other liquid is not needed to swallow the dose.
|
7.
|
Actos 30mg tablets can be taken with or without food.
|
Moreover, in patients with a baseline haemoglobin of > 13 g/ dl, the possibility that epoetin alfa treatment may be associated with an increased risk of postoperative thrombotic/ vascular events cannot be excluded.
|
Correction Phase
|
Why has ATryn been approved?
|
NAME OF THE MEDICINAL PRODUCT
|
In addition, rosiglitazone preserved ß-cell function as shown by increased pancreatic islet mass and insulin content and prevented the development of overt hyperglycaemia in animal models of type 2 diabetes.
|
Intercurrent infections, inflammatory or traumatic episodes, occult blood loss, haemolysis, severe aluminium toxicity, underlying haematologic diseases, or bone marrow fibrosis may also compromise the erythropoietic response.
|
PHARMACEUTICAL FORM AND CONTENTS
|
A special pack with the correct quantities of both strengths of tablets is available when initiating treatment.
|
The lack of carcinogenic potential was demonstrated in studies conducted with desloratadine and loratadine.
|
No interaction was observed when ibandronic acid was administered concomitantly with tamoxifen, or melphalan/ prednisolone.
|
L1 protein in the form of non-infectious virus-like particles (VLPs) produced by recombinant DNA technology using a Baculovirus expression system which uses Hi-5 Rix4446 cells derived from Trichoplusia ni.
|
If signs of toxicity are noted (e. g. pronounced adverse reactions - see section 4.8) the dose of Advagraf may need to be reduced.
|
The recommended oral dose in hepatic transplant patients is 1.5 g administered twice daily (3 g daily dose).
|
Keep out of the reach and sight of children.
|
2.
|
STATEMENT OF ACTIVE SUBSTANCE(S)
|
(NaH2PO4.2 H2O) and water for injections.
|
Patients receiving aripiprazole solution for injection should be observed for orthostatic hypotension.
|
Neuroleptic Malignant Syndrome (NMS):
|
ESAs are not indicated for use in this patient population.
|
4.
|
Due to its increased carbohydrate content darbepoetin alfa has a longer terminal half-life than r-HuEPO and consequently a greater
|
You may need to read it again.
|
8.
|
Do not freeze.
|
– The active substance is insulin human made by recombinant biotechnology.
|
In this situation, a reduced dose of atorvastatin should be considered.
|
Maintenance dose between 25 and 50 IU/ kg 2 times per week into 2 equal injections.
|
Activated Factor X converts prothrombin to thrombin.
|
LIST OF EXCIPIENTS
|
- hepatic impairment
|
NAME OF THE MARKETING AUTHORISATION HOLDER
|
Intramuscular use
|
Specific interaction studies with antidiabetic agents were not conducted.
|
medicine.
|
No data are available to recommend the use of CellCept in children who have received a heart transplant.
|
Many of these patients were also receiving chemotherapy and corticosteroids.
|
Upon regaining consciousness, administration of oral carbohydrate is recommended for the patient in order to prevent relapse.
|
The study lasted six months.
|
Aloxi should not be used in people who may be hypersensitive (allergic) to palonosetron or any of the other ingredients.
|
4.4 Special warnings and precautions for use
|
It has been shown in man that administration of an oral suspension of activated powdered charcoal or colestyramine leads to a rapid and significant increase in A771726 elimination rate and decline in plasma concentrations (see section 4.9).
|
Common:
|
The co-administration of tipranavir with vitamin E in the form of TPGS (d-alphatocopherol polyethylene glycol 1000 succinate) from 2,322 IU/ m² upwards in rats resulted in a significant increase in effects on coagulation parameters, bleeding events and death.
|
NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION
|
On rare occasions, injection site reactions may require discontinuation of Actraphane.
|
n
|
Pseudoephedrine sulphate carries the risk of abuse.
|
Gran Vía Carlos III, 94 E- 08028 Barcelona Tel.: +34 93 600 37 00
|
General disorders and administration site conditions
|
In the case of the following haemorrhagic events, the factor IX activity should not fall below the given plasma activity levels (in% of normal or in IU/ dl) in the corresponding period.
|
The other two studies involved a total of 1,159 patients with later stage disease, where AZILECT was added to the patients’ existing treatment including levodopa.
|
40 Injecting yourself
|
180 film-coated tablets
|
Retapamulin is a semi-synthetic derivative of the compound pleuromutilin, which is isolated through fermentation from Clitopilus passeckerianus (formerly Pleurotus passeckerianus).
|
Very rare:
|
Once the therapeutic objective for an individual patient has been achieved, the dose should be reduced by 25 to 50% in order to ensure that the lowest approved dose of Aranesp is used to maintain haemoglobin at a level that controls the symptoms of anaemia.
|
The Committee recommended that Biograstim be given marketing authorisation.
|
Renal impairment: no dosage adjustment is necessary in patients with impaired renal function.
|
You should watch for a temperature of 37.8 °C or above, chills or other signs of infection, such as a rash, sore throat, diarrhoea, ear-ache, difficult or painful breathing or problems such as cough or wheezing.
|
2.
|
Tel: + 356 25600 500 Nederland Eli Lilly Nederland B. V.
|
AUC0-∞ (IU· h/ dl) t1/ 2 (h) Adjusted Recovery
|
Aspartate aminotransferase increased, ejection fraction decreased, blood creatinine increased, alanine aminotransferase increased
|
Film-coated tablets 11 x 0.5 mg and 14 x 1 mg
|
EU/ 1/ 07/ 410/ 016
|
The injections are given in the thighs or the anterior abdominal wall.
|
Ask your doctor, pharmacist or nurse for advice before taking any medicine.
|
15.4 (56.4)
|
- tendonitis (pain caused by inflammation in the membrane surrounding the tendons usually in the
|
14 After removing Actraphane vial from the refrigerator it is recommended to allow the vial to reach room temperature (not above 25°C) before resuspending the insulin as instructed for first time use.
|
POSSIBLE SIDE EFFECTS
|
General
|